IDEXX LABORATORIES NORGE AS
Operating
Forskning, utvikling, produksjon, markedsføring, salg og distribusjon
av produkter og tjenesteyting innen områdene veterinærvitenskap,
næringsmidler, naturmiljø og helse, herunder å utvikle, produsere,
distribuere, markedsføre og selge diagnostiske produkter, tester,
utstyr, tilbehør og relaterte tjenester på det menneskelige felt som
kan brukes på eller brukes i menneskekroppen (in vitro), samt annen
virksomhet i tilknytning til dette, herunder deltakelse i andre
selskaper.
Forskning, utvikling, produksjon, markedsføring, salg, distribusjon av
produkter og tjenesteyting innen områdene vetrinærvitenskap, helse,
næringsmidler og naturmiljø samt annen virksomhet i tilknytning til
dette, herunder deltakelse i andre selskaper.
Organization
- Chairman of the board
- HW
- Years since formation
- 15 years
- since Dec 12, 2011
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 10
Ownership
- Number of shares and share classes
- 1,000
- 1 share class
- Total number of shareholders
- 1
- person
Financials
- Total operating income 2025
- 19,932,197
- NOK
- Annual total result 2025
- 4,328,850
- NOK
- Total equity 2025
- 22,145,446
- NOK
Last update: Nov 7, 2026
Management
Board
| Name | Role | Shares |
|---|---|---|
HW | Chairman | - |
LJ 1972 | Board Member | - |
AM 1977 | Board Member | - |
JD | Board Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Auditor | - | |
| Accountant | - | |
| Accountant | - | |
| Accountant | - |
Last update: Nov 7, 2026
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
IB | Ordinary shares | 1,000 | 100 % |
Last update: Sep 25, 2026
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 19,932,197 | 16,587,205 | 14,077,124 | 12,924,844 | 102,547,857 |
Annual Total Result | 4,328,850 | 2,993,942 | 2,161,865 | 1,713,000 | 1,317,583 |
Total assets | 46,453,907 | 39,984,781 | 31,258,502 | 24,891,432 | 29,521,148 |
Total liabilities | 24,308,461 | 22,168,185 | 16,435,848 | 12,230,644 | 18,573,360 |
Total equity | 22,145,446 | 17,816,596 | 14,822,654 | 12,660,787 | 10,947,788 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 19,932,197 | 16,587,205 | 14,077,124 | 12,924,844 | 102,547,857 |
Total operating costs | 14,369,762 | 12,707,848 | 11,301,380 | 10,699,500 | 100,859,664 |
Operating result | 5,562,435 | 3,879,357 | 2,775,744 | 2,225,344 | 1,688,193 |
Financial income/costs | 14,455 | -27,604 | 15,152 | -16,191 | 6,991 |
Profit before tax | 5,576,890 | 3,851,753 | 2,790,896 | 2,209,153 | 1,695,184 |
Total tax & extraordinary income/cost | 1,248,040 | 857,811 | 629,031 | 496,153 | 377,601 |
Annual Total Result | 4,328,850 | 2,993,942 | 2,161,865 | 1,713,000 | 1,317,583 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 960,142 | 1,045,343 | 359,807 | 451,059 | 684,988 |
Total current assets | 45,493,765 | 38,939,438 | 30,898,695 | 24,440,373 | 28,836,160 |
Total assets | 46,453,907 | 39,984,781 | 31,258,502 | 24,891,432 | 29,521,148 |
Short term debt | 24,308,461 | 21,548,721 | 15,755,347 | 11,492,430 | 17,787,000 |
Long term debt | 0 | 619,464 | 680,501 | 738,214 | 786,360 |
Total liabilities | 24,308,461 | 22,168,185 | 16,435,848 | 12,230,644 | 18,573,360 |
Contributed capital | 120,000 | 120,000 | 120,000 | 120,000 | 120,000 |
Retained earnings | 22,025,446 | 17,696,596 | 14,702,654 | 12,540,787 | 10,827,788 |
Total equity | 22,145,446 | 17,816,596 | 14,822,654 | 12,660,787 | 10,947,788 |
Total equity and liabilities | 46,453,907 | 39,984,781 | 31,258,502 | 24,891,431 | 29,521,148 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification